| [1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin,2015,65(1):5-29.
|
| [2] |
Clemons M, Goss P. Estrogen and the risk of breast cancer [J]. N Engl J Med,2001,344(4):276-285.
|
| [3] |
Clamp A, Danson S, Clemons M. Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies [J]. Lancet Oncol,2002,3(10):611-619.
|
| [4] |
Bai Z, Gust R. Breast cancer, estrogen receptor and ligands[J]. Arch Pharm (Weinheim),2009,342(3):133-149.
|
| [5] |
Kim H, Abd Elmageed ZY, Ju J, et al. PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth[J]. Mol Med, 2013, 19:253-262.
|
| [6] |
Dunbier AK, Anderson H, Ghazoui Z, et al. Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women[J].J Clin Oncol,2010,28(7):1161-1167.
|
| [7] |
Michailidou K, Beesley J, Lindstrom S, et al. Genome-wide association analysis of more than 120 000 individuals identifies 15 new susceptibility loci for breast cancer [J]. Nat Genet, 2015, 47(4):373-380.
|
| [8] |
Kocher O, Comella N, Tognazzi K, et al. Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains[J]. Lab Invest,1998,78(1):117-125.
|
| [9] |
Wang S, Yue H,Derin RB, et al. Accessory protein facilitated CFTRCFTR interaction, a molecular mechanism to potentiate the chloride channel activity [J]. Cell,2000,103(1):169-179.
|
| [10] |
O Leary PC, Penny SA, Dolan RT, et al. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer [J].BMC Cancer,2013,13:175.
|
| [11] |
Pavlou MP, Dimitromanolakis A, Diamandis EP. Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer [J]. Proteomics,2013,13(7):1083-1095.
|
| [12] |
Kim H, Abd Elmageed ZY, Davis C, et al. Correlation between PDZK1, Cdc37, Akt and breast cancer malignancy: the role of PDZK1 in cell growth through Akt stabilization by increasing and interacting with Cdc37[J]. Mol Med,2014,20:270-279.
|
| [13] |
Haynes BP, Viale G,Galimberti V,et al. Expression of key oestrogenregulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer[J]. Breast Cancer Res Treat,2013,138(1):157-165.
|
| [14] |
Maras M, Vanparys C, Muylle F, et al. Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation[J]. Environ Health Perspect,2006,114(1):100-105.
|
| [15] |
Kim H, Tarhuni A, Abd Elmageed ZY, et al. Poly(ADP-ribose)polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axis[J]. J Transl Med,2015,13:233.
|
| [16] |
Eroles P, Bosch A, Pérez-Fidalgo JA, et al. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways[J]. Cancer Treat Rev,2012,38(6):698-707.
|
| [17] |
Freudenberg JA, Wang Q, Katsumata M, et al. The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies[J]. Exp Mol Pathol,2009,87(1):1-11.
|
| [18] |
Renoir JM, Marsaud V, Lazennec G. Estrogen receptor signaling as a target for novel breast cancer therapeutics[J]. Biochem Pharmacol,2013,85(4):449-465.
|
| [19] |
Moulder SL. Does the PI3K pathway play a role in basal breast cancer?[J]. Clin Breast Cancer,2010,10 Suppl 3:S66-71.
|
| [20] |
Mackay A, Urruticoechea A, Dixon JM, et al. Molecular response to aromatase inhibitor treatment in primary breast cancer[J]. Breast Cancer Res,2007,9(3):R37.
|
| [21] |
Ghosh MG, Thompson DA, Weigel RJ. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer[J]. Cancer Res,2000,60(22):6367-6375.
|
| [22] |
Englert NA, Spink BC, Spink DC. Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells [J]. J Steroid Biochem Mol Biol,2011,123(3/5):140-150.
|
| [23] |
Shimizu T, Sugiura T, Wakayama T, et al. PDZK1 regulates breast cancer resistance protein in small intestine[J]. Drug Metab Dispos,2011,39(11):2148-2154.
|